Portfolio company
Aplex Bio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Aplex Bio develops hyperplexed PCR kits for clinical laboratories and researchers to detect over one hundred target molecules simultaneously in a single sample.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Molecular Designs
The company develops and manufactures multiplex PCR assays and nucleic acid extraction systems for clinical laboratories and research institutions.
Syndex Bio
This company develops a polymerase chain reaction platform that amplifies DNA methylation patterns for clinicians and researchers involved in early disease detection.
Applied BioCode
The company manufactures multiplex diagnostic assays and instruments for clinical and research laboratories to detect infectious diseases and pathogens.
Apton Biosystems
Apton Biosystems develops high-throughput DNA sequencing and single-molecule detection systems for clinical researchers and laboratories performing large-scale genomic analysis.
ChromaCode
This company provides genomics multiplexing platforms and software to clinical laboratories, enabling rapid molecular diagnostics testing using existing polymerase chain reaction instrumentation.
Nplex Biosciences
This company develops high-throughput proteomics platforms for researchers in pharmaceutical and academic sectors to measure proteins for drug and biomarker discovery.
Plexigen
This company develops biochips and instrumentation for genomic and proteomic testing to serve clinical research and diagnostic laboratories.
Palamedrix
This company develops DNA nanotechnology and biosensor platforms for multi-omic detection and proteomic analysis for biopharmaceutical and academic research markets.
